Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GeneNews; Fluidigm; MDS, Promega; AnaSpec

NEW YORK (GenomeWeb News) – GeneNews said this week that it will receive a grant of MYR 5 million (US$1.4 million) from the Malaysian Ministry of Health for a two-year project focused on developing blood-based diagnostic tests for liver cancer, hepatitis B, and nasopharyngeal cancer based on the firm's Sentinel Principle platform.

Fluidigm said that Enza Zaden, a supplier of vegetable seeds for agriculture, has chosen the firm's BioMark System for Genetic Engineering and the 96.96 Dynamic Array to ensure the quality of its feed supply.

MDS Analytical Technologies said this week that its SpectraMax L microplate luminometers have received Dual-Luciferase Reporter Assay certification from Promega. The certification confirms that MDS' luminometers meet Promega's performance criteria for the DLR assay.

AnaSpec announced that it had launched its new headquarter in Fremont, Calif. It said that all of its divisions would be housed within the 44,010-square-feet facility.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.